Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 12, 2021 Category: Drugs & Pharmacology Authors: Uday Kiran Velagapudi Bhargav A. Patel Xuwei Shao Sanjai Kumar Pathak Dana V. Ferraris Tanaji T. Talele Source Type: research

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 3, 2021 Category: Drugs & Pharmacology Authors: Ilaria Vicenti Maurizio Zazzi Francesco Saladini Source Type: research

Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 2, 2021 Category: Drugs & Pharmacology Authors: Nan-Nan Chen Han Zhang Qi-Dong You Xiao-Li Xu Source Type: research

Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 2, 2021 Category: Drugs & Pharmacology Authors: Chirag C. Mehta Hardik G. Bhatt Source Type: research

Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 22, 2021 Category: Drugs & Pharmacology Authors: Elena Lenci Lucrezia Cosottini Andrea Trabocchi Source Type: research

Pharmaceutical price regulation and its impact on drug innovation: mitigating the trade-offs
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 10, 2021 Category: Drugs & Pharmacology Authors: Ashish Kumar Kakkar Source Type: research

Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 10, 2021 Category: Drugs & Pharmacology Authors: Suwen Hu Zi Hui Fr édéric Lirussi Carmen Garrido Xiang-Yang Ye Tian Xie Source Type: research

Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - February 8, 2021 Category: Drugs & Pharmacology Authors: Harbinder Singh Vikrant Rai Sunil K. Nooti Devendra K. Agrawal Source Type: research

Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016 –2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 29, 2021 Category: Drugs & Pharmacology Authors: Hyun Seung Ban Yoshikazu Uto Hiroyuki Nakamura Source Type: research

Inventive step assessment of top selling monoclonal antibodies in Brazil
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 19, 2021 Category: Drugs & Pharmacology Authors: Louise Azulay Palavecino Carlos Rangel Rodrigues Murilo Lamim Bello Alexandre Guimar ães Vasconcellos Source Type: research

Acetylcholinesterase inhibitors for the treatment of Alzheimer ’s disease – a patent review (2016–present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 14, 2021 Category: Drugs & Pharmacology Authors: Martina Bortolami Daniele Rocco Antonella Messore Roberto Di Santo Roberta Costi Valentina Noemi Madia Luigi Scipione Fabiana Pandolfi Source Type: research

An updated patent review of autotaxin inhibitors (2017 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 12, 2021 Category: Drugs & Pharmacology Authors: Zehui Tan Hongrui Lei Ming Guo Yuxiang Chen Xin Zhai Source Type: research

The therapeutic potential of PROTACs
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 12, 2021 Category: Drugs & Pharmacology Authors: Andrew B. Benowitz Katherine L. Jones John D. Harling Source Type: research

Therapeutic approaches targeting the neurotensin receptors
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 8, 2021 Category: Drugs & Pharmacology Authors: Malliga R. Iyer George Kunos Source Type: research

Monocyclic beta –lactams for therapeutic uses: a patent overview (2010–2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - January 7, 2021 Category: Drugs & Pharmacology Authors: Katarina Grabrijan Nika Stra šek Stanislav Gobec Source Type: research